The launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...

A recent viral workplace lesson highlights a frustrating paradox: efficiency is often met with micromanagement, not recognition. Imagine tw...

New Labour Codes, effective November 2025, redefine overtime eligibility and calculation. While standard working hours remain, employees wo...

Lucid Motors layoffs 2026 explained: EV maker Lucid Motors is undergoing significant workforce reductions, cutting approximately 18% of its...

A viral post highlights a refreshing shift in workplace culture where a manager openly shared leaving for his daughter's school award. This...

Mumbai's BEST bus services are set to resume after a three-day indefinite strike was called off Sunday night. Following crucial talks with ...

Porsche's CEO anticipates a swift resolution to cost-cutting talks, aiming for employee agreement before July holidays to provide clarity. ...

A key Meta executive overseeing AI tool improvements is departing. Emily Dalton Smith was leading efforts to centralise internal AI tools i...

Meta is hitting a new chapter as Emily Dalton Smith, a key executive with a longstanding history at the company since 2015, exits. Her lead...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

Electronics Mart India is diversifying its store presence beyond Hyderabad due to concerns about potential AI-driven job losses impacting c...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...